vs

Side-by-side financial comparison of BrightView Holdings, Inc. (BV) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

BrightView Holdings, Inc. is the larger business by last-quarter revenue ($614.7M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). BrightView Holdings, Inc. runs the higher net margin — -2.5% vs -10.1%, a 7.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.6%). BrightView Holdings, Inc. produced more free cash flow last quarter ($-18.6M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -4.4%).

BrightView Holdings, Inc. is a leading US commercial landscaping services provider. It offers solutions including landscape design, installation, maintenance, irrigation management, and snow and ice removal, serving corporate campuses, retail centers, residential communities, and public sector properties.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BV vs CLOV — Head-to-Head

Bigger by revenue
BV
BV
1.3× larger
BV
$614.7M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+42.1% gap
CLOV
44.7%
2.6%
BV
Higher net margin
BV
BV
7.6% more per $
BV
-2.5%
-10.1%
CLOV
More free cash flow
BV
BV
$50.4M more FCF
BV
$-18.6M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-4.4%
BV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BV
BV
CLOV
CLOV
Revenue
$614.7M
$487.7M
Net Profit
$-15.2M
$-49.3M
Gross Margin
18.6%
Operating Margin
-1.2%
-10.1%
Net Margin
-2.5%
-10.1%
Revenue YoY
2.6%
44.7%
Net Profit YoY
-46.2%
-123.2%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BV
BV
CLOV
CLOV
Q4 25
$614.7M
$487.7M
Q3 25
$702.7M
$496.6M
Q2 25
$708.3M
$477.6M
Q1 25
$662.6M
$462.3M
Q4 24
$599.2M
$337.0M
Q3 24
$728.7M
$331.0M
Q2 24
$738.8M
$356.3M
Q1 24
$672.9M
$346.9M
Net Profit
BV
BV
CLOV
CLOV
Q4 25
$-15.2M
$-49.3M
Q3 25
$27.7M
$-24.4M
Q2 25
$32.3M
$-10.6M
Q1 25
$6.4M
$-1.3M
Q4 24
$-10.4M
$-22.1M
Q3 24
$25.6M
$-9.2M
Q2 24
$23.5M
$7.4M
Q1 24
$33.7M
$-19.2M
Gross Margin
BV
BV
CLOV
CLOV
Q4 25
18.6%
Q3 25
25.1%
Q2 25
24.1%
Q1 25
22.3%
Q4 24
21.2%
Q3 24
25.0%
24.5%
Q2 24
24.0%
30.3%
Q1 24
22.6%
23.6%
Operating Margin
BV
BV
CLOV
CLOV
Q4 25
-1.2%
-10.1%
Q3 25
7.9%
-4.9%
Q2 25
8.1%
-2.2%
Q1 25
3.4%
-0.3%
Q4 24
-0.1%
-6.4%
Q3 24
7.1%
-2.7%
Q2 24
6.6%
2.0%
Q1 24
9.2%
-6.5%
Net Margin
BV
BV
CLOV
CLOV
Q4 25
-2.5%
-10.1%
Q3 25
3.9%
-4.9%
Q2 25
4.6%
-2.2%
Q1 25
1.0%
-0.3%
Q4 24
-1.7%
-6.6%
Q3 24
3.5%
-2.8%
Q2 24
3.2%
2.1%
Q1 24
5.0%
-5.5%
EPS (diluted)
BV
BV
CLOV
CLOV
Q4 25
$-0.26
Q3 25
$0.21
Q2 25
$0.15
Q1 25
$-0.03
Q4 24
$-0.20
Q3 24
$0.20
Q2 24
$0.10
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BV
BV
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$37.0M
$78.3M
Total DebtLower is stronger
$801.1M
Stockholders' EquityBook value
$1.3B
$308.7M
Total Assets
$3.3B
$541.0M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BV
BV
CLOV
CLOV
Q4 25
$37.0M
$78.3M
Q3 25
$74.5M
Q2 25
$79.1M
Q1 25
$141.3M
Q4 24
$98.3M
$194.5M
Q3 24
$140.4M
$288.0M
Q2 24
$115.9M
$254.8M
Q1 24
$177.3M
$208.3M
Total Debt
BV
BV
CLOV
CLOV
Q4 25
$801.1M
Q3 25
$790.2M
Q2 25
$790.7M
Q1 25
$798.9M
Q4 24
$796.5M
Q3 24
$802.5M
Q2 24
Q1 24
Stockholders' Equity
BV
BV
CLOV
CLOV
Q4 25
$1.3B
$308.7M
Q3 25
$1.3B
$340.9M
Q2 25
$1.3B
$344.2M
Q1 25
$1.3B
$336.1M
Q4 24
$1.3B
$341.1M
Q3 24
$1.3B
$342.2M
Q2 24
$1.3B
$324.9M
Q1 24
$1.2B
$292.5M
Total Assets
BV
BV
CLOV
CLOV
Q4 25
$3.3B
$541.0M
Q3 25
$3.4B
$559.7M
Q2 25
$3.4B
$575.0M
Q1 25
$3.3B
$583.7M
Q4 24
$3.3B
$580.7M
Q3 24
$3.4B
$653.0M
Q2 24
$3.4B
$674.2M
Q1 24
$3.4B
$671.8M
Debt / Equity
BV
BV
CLOV
CLOV
Q4 25
0.64×
Q3 25
0.61×
Q2 25
0.62×
Q1 25
0.63×
Q4 24
0.63×
Q3 24
0.63×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BV
BV
CLOV
CLOV
Operating Cash FlowLast quarter
$36.1M
$-66.9M
Free Cash FlowOCF − Capex
$-18.6M
$-69.0M
FCF MarginFCF / Revenue
-3.0%
-14.1%
Capex IntensityCapex / Revenue
8.9%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.2M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BV
BV
CLOV
CLOV
Q4 25
$36.1M
$-66.9M
Q3 25
$84.4M
$12.1M
Q2 25
$55.7M
$5.4M
Q1 25
$91.2M
$-16.3M
Q4 24
$60.5M
$34.8M
Q3 24
$53.5M
$50.0M
Q2 24
$42.6M
$44.8M
Q1 24
$83.3M
$25.9M
Free Cash Flow
BV
BV
CLOV
CLOV
Q4 25
$-18.6M
$-69.0M
Q3 25
$26.0M
$11.4M
Q2 25
$-47.8M
$4.8M
Q1 25
$57.6M
$-16.5M
Q4 24
$1.8M
$33.3M
Q3 24
$21.1M
$49.6M
Q2 24
$19.3M
$44.4M
Q1 24
$70.7M
$25.5M
FCF Margin
BV
BV
CLOV
CLOV
Q4 25
-3.0%
-14.1%
Q3 25
3.7%
2.3%
Q2 25
-6.7%
1.0%
Q1 25
8.7%
-3.6%
Q4 24
0.3%
9.9%
Q3 24
2.9%
15.0%
Q2 24
2.6%
12.5%
Q1 24
10.5%
7.3%
Capex Intensity
BV
BV
CLOV
CLOV
Q4 25
8.9%
0.4%
Q3 25
8.3%
0.1%
Q2 25
14.6%
0.1%
Q1 25
5.1%
0.0%
Q4 24
9.8%
0.5%
Q3 24
4.4%
0.1%
Q2 24
3.2%
0.1%
Q1 24
1.9%
0.1%
Cash Conversion
BV
BV
CLOV
CLOV
Q4 25
Q3 25
3.05×
Q2 25
1.72×
Q1 25
14.25×
Q4 24
Q3 24
2.09×
Q2 24
1.81×
6.04×
Q1 24
2.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BV
BV

Landscape Maintenance$368.0M60%
Development Services Segment$179.2M29%
Snow Removal$68.4M11%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons